Results 201 to 210 of about 335,213 (265)

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Right Ventricular-Pulmonary Artery Coupling in Patients With Atrial Fibrillation and Changes After Catheter Ablation. [PDF]

J Am Heart Assoc
Hirose K, Nakanishi K, Daimon M, Iwama K, Yoshida Y, Mukai Y, Yamamoto Y, Seki H, Hirokawa M, Nakao T, Oshima T, Matsubara T, Shimizu Y, Oguri G, Kojima T, Hasumi E, Fujiu K, Morita H, Kurano M, Takeda N.   +19 more
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

The preoperative risks of pulmonary hypertension crisis for the cesarean puerpera with pulmonary artery hypertension. [PDF]

BMC Pregnancy Childbirth
Sun Y.
europepmc   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Y-shaped pulmonary artery in modified Fontan surgery: a multimodality imaging case. [PDF]

Quant Imaging Med Surg
Lv R, Wei ZA, Lin X, Tian C, Qiao B.
europepmc   +1 more source

Anomalous origin of the right pulmonary artery from the ascending aorta: a case report and review of the literature. [PDF]

Int J Surg Case Rep
Al-Dairy A, Deeb A, Aldammad Z, Al-Bitar A.   +3 more
europepmc   +1 more source

Prognostic value of right ventricular-pulmonary artery coupling in patients with muscular dystrophies. [PDF]

Sci Rep
Fayssoil A, Mansencal N, Chaffaut C, Wahbi K, Lofaso F, Prigent H, Orlikowski D, Clair B, Laforet P, Bassez G, Behin A, Fontaine B, Becane H-, Duboc D, Dubourg O, Chevret S, Annane D, Stojkovic T.   +17 more
europepmc   +1 more source

Feasibility of Magnetic Resonance Imaging-Guided Pulmonary Artery Stenting in a Commercial Wide-Bore 0.55-T Scanner. [PDF]

JACC Basic Transl Sci
Liu Y, Kelly JM, Swinning J, Liu Y, Joseph M, Jin N, Pang J, Maier F, Krafft AJ, Ooms NA, Roll J, Krieger J, Gross DC, Bramwell O, de Mos L, Borm P, Simonetti OP, Armstrong AK.   +17 more
europepmc   +1 more source

Giant pulmonary artery masquerading as pneumonia. [PDF]

BMJ Case Rep
Blank J, Mansoor AM, Mansoor SE.
europepmc   +1 more source